{
    "organizations": [],
    "uuid": "49b068c216f98e554c02368f834929b94b68d468",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/valeant-reports-profit-in-4th-quarter-on/valeant-reports-profit-in-4th-quarter-on-1-3-billion-tax-benefit-idUSL4N1QI5C8",
    "ord_in_thread": 0,
    "title": "Valeant reports profit in 4th quarter on $1.3 billion tax benefit",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Valeant Pharmaceuticals on Wednesday reported a profit in the fourth quarter compared to a year-earlier loss, as it booked a one-time benefit because of new U.S. tax laws.\nThe Canada-based drugmaker reported a net income of $513 million or $1.45 per share in the quarter ended Dec. 31, compared to a loss of $515 million or $1.47 per share a year earlier.\nIt recorded a one-time benefit from income taxes of $1.32 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar)\n ",
    "published": "2018-02-28T20:10:00.000+02:00",
    "crawled": "2018-03-01T21:25:12.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "valeant",
        "pharmaceutical",
        "wednesday",
        "reported",
        "profit",
        "fourth",
        "quarter",
        "compared",
        "loss",
        "booked",
        "benefit",
        "new",
        "tax",
        "law",
        "drugmaker",
        "reported",
        "net",
        "income",
        "million",
        "per",
        "share",
        "quarter",
        "ended",
        "compared",
        "loss",
        "million",
        "per",
        "share",
        "year",
        "earlier",
        "recorded",
        "benefit",
        "income",
        "tax",
        "billion",
        "reporting",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "sai",
        "sachin",
        "ravikumar"
    ]
}